Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of induced ceramide increase in MOLT-4 cells
Authors:
Open Access
- 22 November 2007
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 22 (6) , 1258-1262
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Involvement of Dihydroceramide Desaturase in Cell Cycle Progression in Human Neuroblastoma CellsJournal of Biological Chemistry, 2007
- Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagyBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- The CLN9 Protein, a Regulator of Dihydroceramide SynthaseJournal of Biological Chemistry, 2006
- The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cellsLeukemia, 2005
- N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytesLeukemia, 2002
- Synergistic Cytotoxicity in Solid Tumor Cell Lines Between N-(4-Hydroxyphenyl)retinamide and Modulators of Ceramide MetabolismJNCI: Journal of the National Cancer Institute, 2000
- Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophagesBioorganic & Medicinal Chemistry Letters, 1998